Pharmaceutical formulation comprising pyrazolo 4,3-d pyrimidines and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists

摘要

"PHARMACEUTICAL FORMULATION UNDERSTANDING PIRAZOLE [4,3-D] ENDHYTHRINE RECEPTOR PYRIMIDINES AND ANTAGONISTS OR ENDHTHININE RECEPTOR ANTEGONISTS". The present invention relates to a pharmaceutical preparation comprising at least one phosphodiesterase V inhibitor having and / or physiologically acceptable salt and / or solvates thereof and at least one endothelin receptor antagonist for the preparation of a medicament for the treatment of angina. , high blood pressure, high lung pressure, congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), pulmonary heart, dextrocardiac failure, atherosclerosis, reduced cardiac vessel patency conditions, peripheral vascular disease, stroke, bronchitis, allergic asthma, chronic asthma, allergic rhinitis, glaucoma, irritable bowel syndrome, tumors, kidney failure, liver cirrhosis, erectile dysfunction and for the treatment of female sexual disorders.